INVIVYD ALERT: Bragar Eagel & Squire, P.C. is Investigating Invivyd, I...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 20, 2024

Divert Announces Purchase of New Site in Lexington, North Carolina for Future Integrated Diversion & Energy Facility • Kellanova and Shaw's join No Kid Hungry to help end summer hunger for kids and families in Maine • H2 Green Mining and Ohmium Sign Agreement to Boost Green Hydrogen in Chile • Coming into Force of Algonquins of Pikwakanagan First Nation's Child and Family Services Law, Nigig Nibi Ki-win • Prime Minister announces appointment of the next Commissioner of the Northwest Territories • Eaton to announce first quarter 2024 earnings on April 30, 2024 • University of Phoenix College of Nursing Faculty Leadership Selected for Prestigious Fellows of the American Association of Nurs • T2EARTH Launches Official YouTube Channel – T2EARTH Talks • Engel & Völkers Dallas Fort Worth Presents $20,824 to Special Olympics • Island Fin Poké Co. Celebrates Earth Day by Sharing Its Sustainable Efforts Toward a Greener Earth • LS Cable & System Welcomes $99 Million Investment Tax Credit Under Section 48C of the Inflation Reduction Act • El Car Wash Partners With “CARD” to Support Neurodiversity in the Workplace • Clarification of Details Regarding Oceansix's Engagement with RB Milestone Group LLC • Hartford HealthCare makes Earth-friendly pledge of carbon neutrality by 2050 • Boys & Girls Clubs of the Valley and Ross Stores Celebrated 10-Year Anniversary of "Help Local Kids Thrive" In-Store Fundrai • T2EARTH Celebrates Earth Day by Leading the Wood Products Industry towards a Sustainable Built Environment • Energy Transition Accelerator Advances with New Secretariat, Expert Consultative Group • Strengthening Canadian research and innovation • USAA to Gift Vehicles to Military and Their Families in 2024 • Statement from the Minister of Indigenous Services on the preliminary findings from the United Nations Special Rapporteur on the

INVIVYD ALERT: Bragar Eagel & Squire, P.C. is Investigating Invivyd, Inc. on Behalf of Long-Term Stockholders and Encourages

NEW YORK , May 27 /Businesswire/ - Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Invivyd, Inc. (NASDAQ: IVVD) on behalf of long-term stockholders following a class action complaint that was filed against Invivyd on January 31, 2023 with a Class Period from November 29, 2021 to December 14, 2021. Our investigation concerns whether the board of directors of Invivyd have breached their fiduciary duties to the company.

The plaintiff alleges that, the defendants failed to disclose that the published epitope mapping, structural studies, and sequence analyses which defendants had used to claim ADG20 was effective against the Omicron variant were insufficient, unreliable, and inadequate to make claims of effectiveness of ADG20 against Omicron, that that defendants' claims regarding ADG20's efficacy against Omicron lacked a reasonable factual basis, and that ADG20 was over 300 times less effective against the Omicron variant as compared to its effectiveness against previous variants.

If you are a long-term stockholder of Invivyd, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.